Implicit|20|07||||232|1||while||Expansion.List||||Wr|Comm|Null|Null||||183..230|1,0|Merck & Co. reported a 25% increase in earnings|Inh|Null|Null|Null||||232..269|1,2,0|Warner-Lambert Co. 's profit rose 22%|Inh|Null|Null|Null|||||||||
Explicit|20|07|270..273|1,2,1|and|||and|||Expansion.List||||Wr|Comm|Null|Null||||232..269|1,2,0|Warner-Lambert Co. 's profit rose 22%|Inh|Null|Null|Null||||274..312|1,2,2|Eli Lilly & Co. 's net income rose 24%|Inh|Null|Null|Null|||||||||
Implicit|20|07||||314|2||on the whole||Expansion.Restatement.Generalization||||Wr|Comm|Null|Null||||183..312|1|Merck & Co. reported a 25% increase in earnings; Warner-Lambert Co. 's profit rose 22% and Eli Lilly & Co. 's net income rose 24%|Inh|Null|Null|Null||||314..366|2|The results were in line with analysts' expectations|Inh|Null|Null|Null|||||||||
Implicit|20|07||||517|5||although||Comparison.Contrast||||Wr|Comm|Null|Null||||384..515|4|Merck, Rahway, N.J., continued to lead the industry with a strong sales performance in the human and animal health-products segment|Inh|Null|Null|Null||||517..619|5|A stronger U.S. dollar reduced third-quarter and first-nine-month sales growth 2% and 3%, respectively|Inh|Null|Null|Null|||||||||
Implicit|20|07||||621|6||in particular||Expansion.Restatement.Specification||||Wr|Comm|Null|Null||||517..619|5|A stronger U.S. dollar reduced third-quarter and first-nine-month sales growth 2% and 3%, respectively|Inh|Null|Null|Null||||621..735|6|International sales accounted for 47% of total company sales for the nine months, compared with 50% a year earlier|Inh|Null|Null|Null|||||||||
EntRel|20|07||||737|7|||||||||||||||621..735|6|International sales accounted for 47% of total company sales for the nine months, compared with 50% a year earlier||||||||737..799|7|Sales for the quarter rose to $1.63 billion from $1.47 billion|||||||||||||
Implicit|20|07||||989|9||in addition||Expansion.Conjunction||||Wr|Comm|Null|Null||||803..987|8|Mevacor, Merck's new cholesterol-lowering drug, had higher sales than any other prescription medicine has ever achieved in the U.S. in the year following introduction, the company said|Inh|Null|Null|Null||||989..1038|9|The drug was introduced in West Germany this year|Inh|Null|Null|Null|||||||||
Explicit|20|07|1061..1068|10,2|however|||however|||Comparison.Contrast.Opposition||||Wr|Comm|Null|Null||||803..969|8,0|Mevacor, Merck's new cholesterol-lowering drug, had higher sales than any other prescription medicine has ever achieved in the U.S. in the year following introduction|Ot|Comm|Null|Null|971..987|8,1;8,2;8,3;8,4|the company said|1040..1059;1070..1195|10,0;10,1;10,3;10,4;10,5|Intense competition led to unit sales declines for a group of Merck's established human and animal-health products, including Aldomet and Indocin|Inh|Null|Null|Null|||||||||
Implicit|20|07||||1578|14||as a result||Contingency.Cause.Result||||Wr|Comm|Null|Null||||1322..1481|13|Warner-Lambert, Morris Plains, N.J., reported sales that were a record for any quarter and the eighth quarter in a row of 20% or more per-share earnings growth|Inh|Null|Null|Null||||1578..1619|14,3,1,0;14,3,1,1,0;14,3,1,1,1,0;14,3,1,1,1,1,0;14,3,1,1,1,1,1;14,3,1,1,1,1,2|1989 will be the best year in its history|Ot|Comm|Null|Null|1558..1577|14,1;14,2;14,3,0;14,4|Warner-Lambert said||||||
Implicit|20|07||||1696|15||while||Expansion.Conjunction||||Wr|Comm|Null|Null||||1621..1694|14,3,1,1,1,1,3|with per-share earnings expected to increase more than 20% to about $6.10|Inh|Null|Null|Null||||1696..1758|15|Sales for the quarter rose to $1.11 billion from $1.03 billion|Inh|Null|Null|Null|||||||||
Implicit|20|07||||1837|16||by comparison||Comparison.Contrast.Juxtaposition||||Wr|Comm|Null|Null||||1762..1835|16,0|Prescription-drug world-wide sales rose 9% in the quarter to $340 million|Inh|Null|Null|Null||||1837..1856|16,2|U.S. sales rose 15%|Inh|Null|Null|Null|||||||||
Implicit|20|07||||1858|17||in particular||Expansion.Restatement.Specification||||Wr|Comm|Null|Null||||1837..1856|16,2|U.S. sales rose 15%|Inh|Null|Null|Null||||1858..1987|17|The segment's growth was led by sales of the cardiovascular drugs Lopid, a lipid regulator, and Dilzem, a calcium channel blocker|Inh|Null|Null|Null|||||||||
Implicit|20|07||||2191|18||by comparison||Comparison.Contrast.Juxtaposition||||Wr|Comm|Null|Null||||1991..2189|18,0|World-wide sales of Warner-Lambert's non-prescription health-care products, such as Halls cough tablets, Rolaids antacid, and Lubriderm skin lotion, increased 3% to $362 million in the third quarter|Inh|Null|Null|Null||||2191..2209|18,2|U.S. sales rose 5%|Inh|Null|Null|Null|||||||||
Explicit|20|07|2242..2246|19,1|also|||also|||Expansion.Conjunction||||Wr|Comm|Null|Null||||1762..1856;1991..2209|16;18|Prescription-drug world-wide sales rose 9% in the quarter to $340 million; U.S. sales rose 15% World-wide sales of Warner-Lambert's non-prescription health-care products, such as Halls cough tablets, Rolaids antacid, and Lubriderm skin lotion, increased 3% to $362 million in the third quarter; U.S. sales rose 5%|Inh|Null|Null|Null||||2213..2241;2247..2279|19,0;19,2;19,3|Confectionery products sales had strong growth in the quarter|Inh|Null|Null|Null|||||||||
Implicit|20|07||||2281|20||in particular||Expansion.Restatement.Specification||||Wr|Comm|Null|Null||||2213..2279|19|Confectionery products sales also had strong growth in the quarter|Inh|Null|Null|Null||||2281..2397|20|World-wide sales of Trident gum, Certs breath mints, and Clorets gum and breath mints, increased 12% to $277 million|Inh|Null|Null|Null|||||||||
Implicit|20|07||||3144|26||while||Expansion.Conjunction||||Wr|Comm|Null|Null||||3041..3142|25|Third-quarter sales of the Indianapolis, Ind., company rose 11% to $1.045 billion from $940.6 million|Inh|Null|Null|Null||||3144..3220|26|Nine-month sales grew 12% to $3.39 billion from $3.03 billion a year earlier|Inh|Null|Null|Null|||||||||
Implicit|20|07||||3287|28||meanwhile||Expansion.Conjunction||||Wr|Comm|Null|Null||||3224..3285|27|Sales of Prozac, an anti-depressant, led drug-sales increases|Inh|Null|Null|Null||||3287..3481|28,0|Higher sales of pesticides and other plant-science products more than offset a slight decline in the sales of animal-health products to fuel the increase in world-wide agricultural product sales|Ot|Comm|Null|Null|3483..3493|28,1;28,2;28,3;28,4|Lilly said||||||
